Disease: Polymorphic Catecholergic Ventricular Tachycardia
- A Case Report of Elective Bilateral Proximal Intercostal Blocks Used to Prevent Arrhythmia in Catecholaminergic Polymorphic Ventricular Tachycardia
- A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
- A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia
- A novel RyR2 mutation associated with co-morbid catecholaminergic polymorphic ventricular tachycardia (CPVT) and benign epilepsy with centrotemporal spikes (BECTS)
- An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia
- Anesthetic Management of a Patient With Catecholaminergic Polymorphic Ventricular Tachycardia
- Application and validation of phenotype-enhanced variant classification in East Asian patients with catecholaminergic polymorphic ventricular tachycardia
- Assessing the impact and safety of implantable cardioverter defibrillators in treating catecholaminergic polymorphic ventricular tachycardia: a systematic review and meta-analysis protoc
- Assessment of paediatric exertional or peri-exertional syncope: does the story matter?
- Avoiding fatal implantable cardioverter-defibrillator complications in patients with catecholaminergic polymorphic ventricular tachycardia by not implanting them
- Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- Benefit of Implantable Cardioverter-Defibrillators in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia-Reply
- Bilateral cardiac sympathetic denervation for refractory arrhythmia in an individual with catecholaminergic polymorphic ventricular tachycardia associated with T-cell-mediated ganglionitis
- Burst Exercise Testing Can Unmask Arrhythmias in Patients With Incompletely Penetrant Catecholaminergic Polymorphic Ventricular Tachycardia
- Ca2+-dependent modulation of voltage-gated myocyte sodium channels
- Calcium Handling in Inherited Cardiac Diseases: A Focus on Catecholaminergic Polymorphic Ventricular Tachycardia and Hypertrophic Cardiomyopathy
- Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R
- CaMKII inhibition has dual effects on spontaneous Ca<sup>2+</sup> release and Ca<sup>2+</sup> alternans in ventricular cardiomyocytes from mice with a gain-of-function RyR2 mutation
- Cardiac Arrest in a Young Woman: A Near Miss Diagnosis
- Cardiac channelopathies in the context of hereditary arrhythmia syndromes
- Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia
- Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
- Catecholaminergic polymorphic ventricular tachycardia (and seizure) caused by a novel homozygous likely pathogenic variant in CASQ2 gene
- Catecholaminergic polymorphic ventricular tachycardia (CPVT): an insidious disease that can often lead to sudden cardiac death in young people
- Catecholaminergic polymorphic ventricular tachycardia in pregnancy: a case report
- Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies
- Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies
- Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential
- Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome
- Clinical and genetic analysis of five children with Catecholaminergic polymorphic ventricular tachycardia due to variants of RYR2 gene
- Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia
- Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry
- COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper
- CPVT-associated calmodulin variants N53I and A102V dysregulate Ca2+ signalling via different mechanisms
- CRISPR/Cas9 Gene Editing of RYR2 in Human iPSC-Derived Cardiomyocytes to Probe Ca<sup>2+</sup> Signaling Aberrancies of CPVT Arrhythmogenesis
- Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2
- Dexmedetomidine inhibited arrhythmia susceptibility to adrenergic stress in RyR2<sup>R2474S</sup> mice through regulating the coupling of membrane potential and intracellular calcium
- Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor
- Diverse Phenotypic Manifestations in a Family with a Novel RYR2 E4107A Variant
- Documenting the descent - remote monitoring and adult-onset Catecholaminergic Polymorphic Ventricular Tachycardia associated with ventricular fibrillation and bradycardia
- Dual-Dye Optical Mapping of Hearts from RyR2 R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
- Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia
- Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death
- Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia
- Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia
- Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation
- Generation of an induced pluripotent stem cell line from a Chinese Han child with catecholaminergic polymorphic ventricular tachycardia
- Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line
- Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene
- Generation of iPSC lines from CPVT patient carrying heterozygous mutation p.A2254V in the ryanodine receptor 2 gene
- Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations
- GENESIS: Gene-Specific Machine Learning Models for Variants of Uncertain Significance Found in Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome-Associated Genes
- Genetic generalized epilepsy with catecholaminergic polymorphic ventricular tachycardia complicated by ryanodine receptor 2 variant: A case report
- Genetic Loss of <em>I</em><sub>K1</sub> Causes Adrenergic-Induced Phase 3 Early Afterdepolariz ations and Polymorphic and Bidirectional Ventricular Tachycardia
- Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
- How does flecainide impact RyR2 channel function?
- Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1
- Impact of genetic tests on survivors of paediatric sudden cardiac arrest
- Impaired Binding to Junctophilin-2 and Nanostructural Alteration in CPVT Mutation
- Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2
- Increased susceptibility to ventricular arrhythmia at low-normal and moderately low levels of extracellular potassium in catecholaminergic polymorphic ventricular tachycardia
- Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia
- Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia
- MICAL1 constrains cardiac stress responses and protects against disease by oxidizing CaMKII
- Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants
- Molecular Dynamics Simulations of the Cardiac Ryanodine Receptor Type 2 (RyR2) Gating Mechanism
- Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor
- Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- Novel cases of pediatric sudden cardiac death secondary to TRDN mutations presenting as long QT syndrome at rest and catecholaminergic polymorphic ventricular tachycardia during exercise: The TRDN arrhythmia syndrome
- Novel RyR2 Mutation (G3118R) Is Associated With Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis
- Novel variants in <em>TECRL</em> leading to catecholaminergic polymorphic ventricular tachycardia
- Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers
- Pacing Dynamics Determines the Arrhythmogenic Mechanism of the CPVT2-Causing CASQ2<sup>G112+5X</sup> Mutation in a Guinea Pig Ventricular Myocyte Computational Model
- Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist
- Peripartum management of a patient with catecholaminergic polymorphic ventricular tachycardia
- Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5
- Pregnancy in catecholaminergic polymorphic ventricular tachycardia: therapeutic optimization and multidisciplinary care are key to success
- Protein expression profiles in murine ventricles modeling catecholaminergic polymorphic ventricular tachycardia: effects of genotype and sex
- Rare RYR2 p.Thr85Ile variant is associated with catecholaminergic polymorphic ventricular tachycardia
- Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia
- Research progress in pathogenesis and treatment of catecholaminergic polymorphic ventricular tachycardia
- RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT
- Smooth Emergence from General Anesthesia after Deep Extubation in a Pediatric Patient Diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report
- SR-Mitochondria Crosstalk Shapes Ca Signalling to Impact Pathophenotype in Disease Models Marked by Dysregulated Intracellular Ca Release
- Stabilizer Cell Gene Therapy: A Less-Is-More Strategy to Prevent Cardiac Arrhythmias
- Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation
- Sudden pediatric cardiac arrest with catecholaminergic polymorphic ventricular tachycardia: When epinephrin should be avoided
- Sudden Unexpected Death after a mild trauma: The complex forensic interpretation of cardiac and genetic findings
- The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT
- The Relationship Between Ventilatory Anaerobic Threshold and Arrhythmia in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia
- Top stories on catecholaminergic polymorphic ventricular tachycardia (2022-2024)
- Trans-2,3-enoyl-CoA reductase-like-related catecholaminergic polymorphic ventricular tachycardia with regular ventricular tachycardia and response to flecainide
- Transient ventricular bigeminy during emergence from general anesthesia in a pediatric patient with catecholaminergic polymorphic ventricular tachycardia
- Update on the effects of ryanodine receptor 2 phosphorylation on the pathogenesis of catecholaminergic polymorphic ventricular tachycardia
- Using hiPSC-CMs to Examine Mechanisms of Catecholaminergic Polymorphic Ventricular Tachycardia
- Young Child With Seizure
- Z16b, a natural compound from Ganoderma cochlear is a novel RyR2 stabilizer preventing catecholaminergic polymorphic ventricular tachycardia